Anthem, the nation’s second-largest health insurer, is planning to push up the launch date of its new pharmacy benefit manager (PBM) business, the company announced during its end-of-year earnings report.

British clinical AI company Sensyne Health and the University of Oxford’s Big Data Institute are partnering to establish a research alliance focused on using AI and digital technology to better understand chronic diseases.

Using an AI-based method, researchers at Cardiff University in Cardiff, Wales, developed a clinical prediction model, according to a study published in PLOS One. The model showed it can provide an accurate and reliable prognosis for patients with cardiovascular disease when compared to traditional methods.

Aetna, in collaboration with Apple, launched a new health application to provide users with personalized health goals. Dubbed Attain, the app will be used in partnership with the Apple Watch to track daily activity levels, recommend healthy actions and incentivize actions taken to improve well-being.

Scientists at the University of Cambridge are developing a machine learning tool to better predict individuals’ long-term risk of developing cardiovascular disease (CVD)—specifically, heart attack or stroke. 

Google’s AI tool for diagnosing diabetic retinopathy is having trouble reading images while it's being tested in an Indian hospital, according to a report by The Wall Street Journal.

A Seattle-based startup, 98point6, is looking to become the Amazon of primary care, according to a profile by CNBC.

In order for AI technology to be safely incorporated into diagnostic and clinical decision support (CDS) software, stakeholders must first address its effectiveness and provide additional evidence for its usefulness in the clinical setting, according to Duke researchers.